• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Moves Lower; Perion Network Shares Tumble

    4/8/24 12:12:36 PM ET
    $AGEN
    $AUUD
    $LGVN
    $PERI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    EDP Services
    Technology
    Get the next $AGEN alert in real time by email

    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 50 points on Monday.

    The Dow traded up 0.21% to 38,983.94 while the NASDAQ rose 0.39% to 16,311.32. The S&P 500 also rose, gaining, 0.24% to 5,216.95.

    Check This Out: Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'

     

    Leading and Lagging Sectors

     

    Consumer discretionary shares jumped by 1% on Monday.

    In trading on Monday, energy shares fell by 0.6%.

     

    Top Headline

     

    Perion Network Ltd. (NASDAQ:PERI) slashed its FY24 revenue guidance.

    Perion Network said it sees first-quarter revenue of $157 million, versus market estimates of $175.53 million. The company said it now expects FY24 revenue of $590 million to $610 million, versus prior outlook of $860 million to $880 million.

     

    Equities Trading UP

     

    Auddia Inc. (NASDAQ:AUUD) shares shot up 250% to $5.03 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers.

    Shares of UTime Limited (NASDAQ:WTO) got a boost, surging 77% to $0.3272 after the company completed a private placement.

    Longeveron Inc. (NASDAQ:LGVN) shares were also up, gaining 78% to $3.92 after the company submitted paperwork for a share offering.

     

    Equities Trading DOWN

     

    Perion Network Ltd. (NASDAQ:PERI) shares dropped 35% to $13.74 after the company slashed FY24 revenue guidance and issued first-quarter outlook below estimates.

    Shares of Agenus Inc. (NASDAQ:AGEN) were down 18% to $0.4113. Agenus disclosed a 1-for-20 reverse stock split of common stock.

    Douglas Dynamics, Inc. (NYSE:PLOW) was down, falling 8% to $22.11. Baird analyst Timothy Wojs downgraded Douglas Dynamics from Outperform to Neutral and lowered the price target from $36 to $25.

    Also Check This Out: This Analyst With 86% Accuracy Rate Sees More Than 16% Upside In Intel - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

     

    Commodities

     

    In commodity news, oil traded down 1.6% to $85.54 while gold traded down 0.1% at $2,342.80.

    Silver traded up 0.1% to $27.51 on Monday, while copper rose 0.4% to $4.2520.

     

    Euro zone

     

    European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.32%, London’s FTSE 100 rose 0.21% while Spain’s IBEX 35 Index fell 0.23% The German DAX gained 0.60% French CAC 40 climbed 0.72% while Italy’s FTSE MIB Index gained 0.61%.

    Imports into Germany increased 3.2% month-over-month to EUR 111.5 billion in February, while exports from Germany fell 2% month-over-month to EUR 132.9 billion. German industrial production climbed by 2.1% month-over-month during February.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Monday, with Japan’s Nikkei 225 gaining 0.91%, Hong Kong’s Hang Seng Index gaining 0.05%, China’s Shanghai Composite falling 0.72% and India’s S&P BSE Sensex gaining 0.67%.

    Foreign exchange reserves in Singapore increased to SGD 497.3 billion in March from SGD 480.4 billion a month ago. The gauge for Japanese service sector declined to 49.8 in March versus 51.3 a month ago. Japan’s current account surplus widened to JPY 2,644.2 billion in February from JPY 2,200.3 billion in the year-ago month. Chinese foreign exchange reserves jumped by $19.8 billion to $3.246 trillion during March.

     

    Economics

     

    There were no major US economic releases Monday.

    Now Read This: Amazon, Alphabet And A Pharmaceutical Giant: CNBC's 'Final Trades'

    Get the next $AGEN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGEN
    $AUUD
    $LGVN
    $PERI

    CompanyDatePrice TargetRatingAnalyst
    Agenus Inc.
    $AGEN
    6/4/2025$25.00Neutral → Buy
    H.C. Wainwright
    Perion Network Ltd.
    $PERI
    5/14/2025$15.00Neutral → Buy
    Roth Capital
    Longeveron Inc.
    $LGVN
    12/6/2024$10.00Buy
    ROTH MKM
    Perion Network Ltd.
    $PERI
    7/31/2024$10.00Hold → Buy
    Lake Street
    Agenus Inc.
    $AGEN
    7/19/2024$35.00 → $8.00Outperform → Neutral
    Robert W. Baird
    Agenus Inc.
    $AGEN
    7/18/2024Outperform → Mkt Perform
    William Blair
    Agenus Inc.
    $AGEN
    7/18/2024$9.00Buy → Neutral
    H.C. Wainwright
    Perion Network Ltd.
    $PERI
    6/10/2024Buy → Hold
    Needham
    More analyst ratings

    $AGEN
    $AUUD
    $LGVN
    $PERI
    SEC Filings

    View All

    Auddia Inc. filed SEC Form 8-K: Other Events

    8-K - AUDDIA INC. (0001554818) (Filer)

    2/2/26 12:01:41 PM ET
    $AUUD
    EDP Services
    Technology

    SEC Form 6-K filed by UTime Limited

    6-K - UTime Ltd (0001789299) (Filer)

    1/28/26 5:20:02 PM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    SEC Form SCHEDULE 13D filed by Agenus Inc.

    SCHEDULE 13D - AGENUS INC (0001098972) (Subject)

    1/23/26 8:57:55 AM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGEN
    $AUUD
    $LGVN
    $PERI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Agenus upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Agenus from Neutral to Buy and set a new price target of $25.00

    6/4/25 7:30:33 AM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Perion Network upgraded by Roth Capital with a new price target

    Roth Capital upgraded Perion Network from Neutral to Buy and set a new price target of $15.00

    5/14/25 8:50:33 AM ET
    $PERI
    EDP Services
    Technology

    ROTH MKM initiated coverage on Longeveron with a new price target

    ROTH MKM initiated coverage of Longeveron with a rating of Buy and set a new price target of $10.00

    12/6/24 7:54:21 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGEN
    $AUUD
    $LGVN
    $PERI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Armen Garo H was granted 5,027 shares, increasing direct ownership by 2% to 320,712 units (SEC Form 4)

    4 - AGENUS INC (0001098972) (Issuer)

    2/9/26 4:05:03 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Officer Armen Garo H was granted 4,562 shares, increasing direct ownership by 1% to 315,685 units (SEC Form 4)

    4 - AGENUS INC (0001098972) (Issuer)

    1/26/26 4:05:04 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    New insider Charette Austin claimed ownership of 9,115 shares (SEC Form 3)

    3 - AGENUS INC (0001098972) (Issuer)

    1/16/26 4:05:11 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGEN
    $AUUD
    $LGVN
    $PERI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Douglas Dynamics Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    MILWAUKEE, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE:PLOW), North America's premier manufacturer and upfitter of work truck attachments and equipment, today announced that it will release financial results for the fourth quarter and full year 2025 after market close on Monday, February 23, 2026. A conference call will be held to discuss the financial results on Tuesday, February 24, 2026 at 9:00 a.m. Central Time, hosted by Mark Van Genderen, President and Chief Executive Officer and Sarah Lauber, Executive Vice President and Chief Financial Officer. The conference call will be simulcast live on the Company's website at: www.douglasdynamics.com. Alternatively, please

    2/10/26 4:55:00 PM ET
    $PLOW
    Construction/Ag Equipment/Trucks
    Industrials

    Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOT/BAL in Immunologically Cold Tumors

    Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology, today announced that new translational and clinical biomarker analyses from its botensilimab (BOT) immunotherapy program have been accepted for poster presentation at the American Association for Cancer Research- Immuno-Oncology (AACR-IO) Conference, taking place in Los Angeles, CA on February 18–21, 2026. The abstract, titled "Systemic and tumor-microenvironment inflammation shape outcomes in patients with immunologically cold, treatment-refractory tumors treated with Fc-enhanced anti–CTLA-4 botensilimab," evaluates how systemic inflammatory markers, tumor microenvironment (TME) immune activity, and peripheral immune cell states are

    2/9/26 1:00:00 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    UTime Limited Announces Reverse Stock Split

    SHENZHEN, China, Feb. 06, 2026 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO) today announced that its share consolidation ("Share Consolidation") involving the consolidation of every five (5) Class A ordinary shares, with a par value of US$0.10 per share, into one (1) class A ordinary share with a par value of US$0.50 per share, will take effect at 8:00 a.m. Eastern Time on February 17, 2026. The Company's Class A Ordinary shares will open for trading on the Nasdaq Capital Market on February 17, 2026, on a post-split basis, under the existing ticker symbol "WTO," with a new CUSIP number of G9411M140. Details of the Share Consolidation The Share Consolidation was approved by the Company'

    2/6/26 8:05:00 AM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    $AGEN
    $AUUD
    $LGVN
    $PERI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Baluch Khoso bought 11,766 shares, increasing direct ownership by 29% to 52,516 units (SEC Form 4)

    4 - Longeveron Inc. (0001721484) (Issuer)

    8/13/25 6:00:07 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Locklear Lisa bought 11,766 shares, increasing direct ownership by 5% to 250,964 units (SEC Form 4)

    4 - Longeveron Inc. (0001721484) (Issuer)

    8/13/25 6:00:08 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Operating Officer Van Genderen Mark bought $114,799 worth of shares (5,000 units at $22.96), increasing direct ownership by 25% to 24,948 units (SEC Form 4)

    4 - DOUGLAS DYNAMICS, INC (0001287213) (Issuer)

    11/5/24 4:38:23 PM ET
    $PLOW
    Construction/Ag Equipment/Trucks
    Industrials

    $AGEN
    $AUUD
    $LGVN
    $PERI
    Financials

    Live finance-specific insights

    View All

    Douglas Dynamics Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    MILWAUKEE, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE:PLOW), North America's premier manufacturer and upfitter of work truck attachments and equipment, today announced that it will release financial results for the fourth quarter and full year 2025 after market close on Monday, February 23, 2026. A conference call will be held to discuss the financial results on Tuesday, February 24, 2026 at 9:00 a.m. Central Time, hosted by Mark Van Genderen, President and Chief Executive Officer and Sarah Lauber, Executive Vice President and Chief Financial Officer. The conference call will be simulcast live on the Company's website at: www.douglasdynamics.com. Alternatively, please

    2/10/26 4:55:00 PM ET
    $PLOW
    Construction/Ag Equipment/Trucks
    Industrials

    Perion to Announce Its Fourth Quarter and Fiscal Year 2025 Financial Results on February 18, 2026

    Perion Network Ltd. (NASDAQ & TASE: PERI), a leader in advanced technology solving for the complexities of modern advertising, announced today it plans to release its financial results for the fourth quarter and fiscal year ended on December 31, 2025, prior to the opening of the financial markets on Wednesday, February 18, 2026. Tal Jacobson, CEO, and Elad Tzubery, CFO, will host a conference call to discuss the results on that day at 8:30 a.m. ET. Earning call registration link: https://perion-q4-and-fy-2025-earnings-call.open-exchange.net/ A replay of the call and a transcript will be available within approximately 24 hours of the live event on the "Investors" section of Perion's webs

    1/27/26 7:00:00 AM ET
    $PERI
    EDP Services
    Technology

    Douglas Dynamics Declares Quarterly Cash Dividend

    MILWAUKEE, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE:PLOW), North America's premier manufacturer and upfitter of work truck attachments and equipment, today announced that its Board of Directors approved and declared a quarterly cash dividend of $0.295 per share for the fourth quarter of 2025. The declared dividend will be paid on December 31, 2025 to stockholders of record on December 16, 2025. About Douglas Dynamics Home to the most trusted brands in the industry, Douglas Dynamics is North America's premier manufacturer and up-fitter of work truck attachments and equipment. For more than 75 years, the Company has been innovating products that not only enable peopl

    12/5/25 8:01:00 AM ET
    $PLOW
    Construction/Ag Equipment/Trucks
    Industrials

    $AGEN
    $AUUD
    $LGVN
    $PERI
    Leadership Updates

    Live Leadership Updates

    View All

    Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France's AAC

    Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology innovation, today announced the appointment of José Iglesias, M.D. as Chief Medical Affairs Officer, effective November 10, 2025. Dr. Iglesias will lead global medical affairs for botensilimab (BOT) and balstilimab (BAL) as the combination advances through Phase 3 evaluation and becomes available in selected countries through early-access mechanisms, including France's Autorisation d'Accès Compassionnel (AAC) program. BOT is an Fc-enhanced multifunctional CTLA-4 antibody and BAL is a PD-1 antibody. In combination, BOT/BAL is being investigated in patients with microsatellite-stable colorectal cancer (MSS CRC), a population that has hi

    11/18/25 8:41:00 AM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors

    MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that George Paletta, Jr., MD, MBA, has been elected to the Longeveron Board of Directors. Dr. Paletta is a nationally and internationally recognized orthopedic surgeon and the head team doctor for the St. Louis Cardinals. Dr. Paletta is a developer of ambulatory surgical centers (ASCs), and has participated in the selling of two ASCs with deal values totaling almost $1 billion. "I am delighted to welcome George, and his tremendous experience as a physician, inv

    10/1/25 4:05:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Auddia Announces Restructuring of Engineering Team in Preparation for Business Combination

    Restructuring projected to reduce engineering costs by $750,000 annually Current lead AI engineer to join the AI engineering team at the holding company level upon closing of the proposed business combination Utilization of internal and dedicated outsourced engineering talent expected to significantly increase the speed of product development BOULDER, Colo., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), an AI first technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with audio, today announced a restructuring of its engineering team aimed at si

    8/25/25 6:12:00 AM ET
    $AUUD
    EDP Services
    Technology

    $AGEN
    $AUUD
    $LGVN
    $PERI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Agenus Inc.

    SC 13G/A - AGENUS INC (0001098972) (Subject)

    11/14/24 7:58:18 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Longeveron Inc.

    SC 13G/A - Longeveron Inc. (0001721484) (Subject)

    11/14/24 4:20:18 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Agenus Inc.

    SC 13G/A - AGENUS INC (0001098972) (Subject)

    11/14/24 9:21:26 AM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care